


Mylan NV Pays $7.2 Billion for Meda AB, Here's Why


Mylan NV plunged the most since 2000 after agreeing to buy Meda AB for about $7.2 billion in cash and stock, adding the Swedish companyâ€™s specialty drug products and European operations.


